Abstract: CONCLUSION: We conclude that in the women included in this study the HPV16 E subtype is 19 times more frequent than the AA subtype; that the circulating E variants are E-P (71.1%) > E-
T350G (18.4%) > E-
C188G (5.3%); that 71.0% of the E-P sequences carry the
A334G single nucleotide change and appear to correspond to a HPV16 variant characteristic of San Luis Potosi City more oncogenic than the E-P Ref prototype.
Abstract: RESULTS: Three European (E) variants (E-P, n = 27; E-
T350G, n = 7; E-
C188G, n = 2) and one AA-a variant (n = 2) were identified among the 38 HPV16 sequences analyzed.
Result: Although the
HSIL +
ICC fraction was even higher for the AA-a, E-